Compare ORIQ & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIQ | ANIX |
|---|---|---|
| Founded | 2024 | 1982 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.0M | 104.0M |
| IPO Year | N/A | N/A |
| Metric | ORIQ | ANIX |
|---|---|---|
| Price | $10.20 | $2.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 37.5K | ★ 201.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.98 | $2.33 |
| 52 Week High | $10.22 | $5.46 |
| Indicator | ORIQ | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 39.98 |
| Support Level | $10.16 | $2.74 |
| Resistance Level | $10.20 | $3.04 |
| Average True Range (ATR) | 0.01 | 0.19 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 75.00 | 35.96 |
Origin Investment Corp I is a blank check company.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.